Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 18, 2000
[The coexistence of breast and ovarian cancer in patient with insertion-duplication of 12bp in BRCA1 gene]B Zubelewicz-Szkodzińska, R Braczkowski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 1, 1995
[Treatment of advanced pancreatic cancer with interferon alpha, tumor necrosis factor and 5-fluorouracil (preliminary report]M Muc, M Baranowski, R Braczkowski
Przeglad Lekarski|March 1, 2000
[Depression as a risk factor for cancer--is it still a hypothesis or a proven fact?]R Braczkowski, B Zubelewicz, K Klakla
Journal of Experimental & Clinical Cancer Research : CR|June 7, 2000
Decline of met-enkephalins concentration after interleukin-2 subcutaneous administration due to renal carcinomaB Zubelewicz, R Braczkowski, W Romanowski, et al.
Polskie Archiwum Medycyny Wewnetrznej|December 1, 1995
[Influence of treatment using recombinant tumor necrosis factor alpha (hrec TNF alpha) on circadian rhythm of cortisol secretion in patients with advanced neoplastic disease]B Zubelewicz, R Braczkowski, W Romanowski, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 1, 1996
[A case of recurrent untreated non-hodgkin's lymphoma localized in the nasopharynx and maxillary sinuses after a 10-year remission]R Braczkowski, B Zubelewicz, M Muc-Wierzgoń, et al.
Journal of Biological Regulators and Homeostatic Agents|September 30, 1999
Central injection of morphine stimulates plasma corticosterone and interleukin (IL)-6 and IL-6 R mRNAs in the pituitary and adrenals in adjuvant-induced arthritisB Zubelewicz, R Braczkowski, D Renshaw, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patientsB Zubelewicz, W Romanowski, B Braczkowska, et al.
Przeglad Lekarski|January 1, 1996
[Cardiotoxic effect of the herec-TNF alpha preparation given intravenously to patients with advanced neoplasms]M Muc, M Baranowski, R Braczkowski, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 1999
Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasmsR Braczkowski, B Zubelewicz, W Romanowski, et al.
Pageof 2